Design and synthesis of substituted N-methylbenzamide analogues derived from SR 48,968 as neurokinin-2 receptor antagonists.
Shih-Chung Huang, Bradley Undem, Vijaya Korlipara
Index: Bioorg. Med. Chem. Lett. 14(18) , 4779-82, (2004)
Full Text: HTML
Abstract
A series of N-methylbenzamide analogues (2-18) that is structurally derived from SR 48,968, a potent neurokinin-2 (NK(2)) receptor antagonist (pK(b)9.1), has been obtained using asymmetric synthesis. Isothiocyanato-N-methylbenzamide (10-12) and bromoacetamido-N-methylbenzamide derivatives (16-18) have been designed to serve as potential electrophilic affinity labels. Nitro-N-methylbenzamide (4-6) and acetamido-N-methylbenzamide (13-15) were designed to serve as the nonelectrophilic controls for these ligands. Functional assay results using guinea pig trachea indicate that electrophilic N-methylbenzamide analogues exhibit potent but surmountable NK(2) receptor antagonist activity. Several members of this series (2, 3, 7-9) exhibit potent NK(2) receptor antagonist potencies with pK(b) values in the range of 9.1-9.7. para-Fluoro substituted analogue 3 was found to be highly potent with a pK(b) of 9.7.
Related Compounds
Related Articles:
2001-11-20
[Biochemistry 40(46) , 13980-9, (2001)]
N-Methylanilide and N-methylbenzamide derivatives as phosphodiesterase 10A (PDE10A) inhibitors.
2013-10-01
[Bioorg. Med. Chem. 21(19) , 6053-62, (2013)]
1986-05-01
[J. Med. Chem. 29(5) , 600-6, (1986)]
1983-06-01
[Biochem. Pharmacol. 32(11) , 1773-81, (1983)]
1992-08-18
[Biochem. Pharmacol. 44(4) , 651-8, (1992)]